Recent Updates
Recently added Catalysts
CUE Positive Sentiment

Viola Meehan

Tuesday, June 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Ms. Viola Meehan has had a distinguished career in finance, serving as CFO of Vanqua Bio until her retirement in January 2023. Prior to that, she held significant roles at AbbVie and Abbott, showcasing her extensive experience in various finance leadership positions. She holds degrees from the Wharton School and the University of Chicago.
Price reaction · baseline $25.68 (2026-06-02T15:33:00.000Z) · hit during market hours · 1 other CUE headline(s) in the window, move may be shared
day 0 close
+11.4%
day 1
+4.8%
day 3 · peak
+14.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ms. Meehan has extensive experience in finance leadership roles.
  • She has a strong educational background with degrees from prestigious institutions.
  • Her career spans over three decades in reputable companies.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+253%
120-day peak, hindsight
Typical move
10.2%
average across 2 past catalysts
Cash runway
~2 mo
High dilution risk
Lead asset
CUE-101
Phase 2 · Head and Neck Squamous Cell Carcinoma

Full Press Release Details

Ms. Meehan served as Chief Financial Officer of Vanqua Bio, Inc. from January 2020 to her retirement in January 2023. From April 2009 to November 2019, Ms. Meehan served as Vice President, Research & Development Finance & Operations group at AbbVie Inc. Ms. Meehan joined Abbott in 1992 and progressed through a wide variety of finance leadership roles supporting Commercial, R&D, Operations, Business Development and other Corporate functions until joining AbbVie Inc. in 2009. Ms. Meehan began her career in public accounting at Price Waterhouse Coopers LLP. Ms. Meehan earned her bachelor’s degree in accounting from the Wharton School of Business at the University of Pennsylvania and her MBA in Finance from the University of Chicago.

Frequently Asked Questions

What roles did Viola Meehan hold at AbbVie?

Viola Meehan served as Vice President of Research & Development Finance & Operations at AbbVie.

Where did Viola Meehan earn her degrees?

She earned her bachelor's degree from the Wharton School and her MBA from the University of Chicago.

When did Viola Meehan retire from Vanqua Bio?

Ms. Meehan retired from Vanqua Bio in January 2023.

What was Viola Meehan's first job?

She began her career in public accounting at Price Waterhouse Coopers LLP.

ShareAdd on Google
Tags: CUE Viatris Investor Conferences Healthcare Vanqua Bio AbbVie finance leadership biopharma
Last updated: Jun 2, 2026

Biotech snapshot

Cash runway
$17M liquidity · $10M/mo burn
~2 mo
High dilution risk
Lead asset
CUE-101Phase 2
Head and Neck Squamous Cell Carcinoma →

Catalyst track record

+253%
best trade around CUE's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for CUE.

See every catalyst's timing & PoA →